TrialPanorama/TrialPanorama-database huggingface dataset:
Study 36104740 — Surrogate Endpoint (SUR): Blood pressure
Study 34298279 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 35000455 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 33993205 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33544533 — Surrogate Endpoint (SUR): Blood pressure
Study 32897310 — Surrogate Endpoint (SUR): Blood pressure
Study 32207709 — Predictive Biomarker (PRD): STC1 mRNA
Genes: STC1; STC
Study 35849214 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 33537000 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33537000 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34103066 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34103066 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36239405 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36239405 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36239405 — Predictive Biomarker (PRD): Hormone receptor
Study 32586078 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 32267878 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study 35637106 — Surrogate Endpoint (SUR): Blood pressure
Study 32703776 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 35331944 — Surrogate Endpoint (SUR): Blood pressure
Study 32756479 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 32756479 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 32589342 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32896456 — Monitoring Biomarker (MOI): HBV DNA
Study 33597586 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33597586 — Safety Biomarker (SAF): Hyaluronic acid
Study 34059848 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 32965797 — Surrogate Endpoint (SUR): Blood pressure
Study 32380894 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 36008598 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32057373 — Predictive Biomarker (PRD): DEGS1 mRNA
Genes: DEGS1; DES1; MLD; MIG15
Study 32852613 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35914511 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study 32444880 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34793244 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32922181 — Surrogate Endpoint (SUR): Blood pressure
Study 34048682 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 35906582 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study 34231179 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study 35219762 — Surrogate Endpoint (SUR): Blood pressure
Study 35219762 — Surrogate Endpoint (SUR): Serum triglycerides
Study 32131642 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35745241 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32004201 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 32004201 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 33934431 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35123855 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35813851 — Safety Biomarker (SAF): BDNF
Study 36410825 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32075474 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 32075474 — Predictive Biomarker (PRD): CXCL16 mRNA
Genes: CXCL16; SCYB16; SRPSOX; UNQ2759/PRO6714
Study 32075474 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 35581997 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 616117878 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 616117878 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34129855 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 34129855 — Predictive Biomarker (PRD): PSMA7 mRNA
Genes: PSMA7; HSPC
Study 34129855 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 34129855 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35000952 — Predictive Biomarker (PRD): DNA repair endonuclease XPF
Genes: ERCC4; ERCC11; XPF
Study 36471334 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 36471334 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33320067 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 35532982 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34111564 — Predictive Biomarker (PRD): DUSP6 mRNA
Genes: DUSP6; MKP3; PYST1
Study 32860041 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 35909888 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35909888 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35909888 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35909888 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 32352494 — Predictive Biomarker (PRD): COL22A1 mRNA
Genes: COL22A1
Study 32352494 — Predictive Biomarker (PRD): FAT3 mRNA
Genes: FAT3; CDHF15; KIAA1989
Study 32379637 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 32379637 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 33217785 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 33217785 — Surrogate Endpoint (SUR): Serum creatinine
Study 33337797 — Surrogate Endpoint (SUR): Blood pressure
Study 36018222 — Surrogate Endpoint (SUR): Blood pressure
Study 33837906 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33293672 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32985122 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 32985122 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32985122 — Surrogate Endpoint (SUR): Bone mineral density
Study 36258233 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36258233 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36258233 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 36258233 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 33667870 — Predictive Biomarker (PRD): TRPV4 mRNA
Genes: TRPV4; VRL2; VROAC
Study 33667870 — Predictive Biomarker (PRD): ATP2A2 mRNA
Genes: ATP2A2; ATP2B
Study 33667870 — Predictive Biomarker (PRD): ITPR1 mRNA
Genes: ITPR1; INSP3R1
Study 33667870 — Pharmacodynamic Biomarker (PDY): Cyclin-dependent kinase 1
Genes: CDK1; CDC2; CDC28A; CDKN1; P34CDC2
Study 33203399 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33683991 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 33377903 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 35757424 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 35341915 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 35275196 — Surrogate Endpoint (SUR): Bone mineral density
Study 35226566 — Predictive Biomarker (PRD): miR-15a-5p
Genes: MIR15A
Study 35226566 — Monitoring Biomarker (MOI): miR-30e-5p
Genes: MIR30E
Study 35226566 — Monitoring Biomarker (MOI): miR-92a-3p
Study 35226566 — Safety Biomarker (SAF): miR-93-5p
Genes: MIR93
Study 32236752 — Surrogate Endpoint (SUR): Bone mineral density
Study 35396879 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 36325897 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 36325897 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 36325897 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35484309 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 36471413 — Predictive Biomarker (PRD): UNC13A mRNA
Genes: UNC13A; KIAA1032
Study 33549489 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 35222888 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 35222888 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33103316 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 32532258 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study 32532258 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 32865377 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36273218 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35619238 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 35565880 — Surrogate Endpoint (SUR): Blood pressure
Study 34762377 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34762377 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35549730 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32162278 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 32205221 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 35238873 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35238873 — Predictive Biomarker (PRD): Hormone receptor
Study 36064594 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 36064594 — Surrogate Endpoint (SUR): Serum uric acid
Study 36064594 — Surrogate Endpoint (SUR): Serum creatinine
Study 36064594 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36064594 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35128820 — Predictive Biomarker (PRD): REG1B mRNA
Genes: REG1B; PSPS2; REGL
Study 36205814 — Surrogate Endpoint (SUR): Blood pressure
Study 32642953 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 35634544 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35477611 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 35477611 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33634859 — Surrogate Endpoint (SUR): Blood pressure
Study 32220632 — Surrogate Endpoint (SUR): Blood pressure
Study 34096066 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study 33902400 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33440370 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33440370 — Safety Biomarker (SAF): IL-6 and IL-10
Study 32172380 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32243363 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33725859 — Predictive Biomarker (PRD): TRAPPC9 mRNA
Genes: TRAPPC9; KIAA1882; NIBP; T1
Study 35440450 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 36058819 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 36058819 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study 33952731 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33952731 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 33657052 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33657052 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33657052 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33657052 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33657052 — Safety Biomarker (SAF): Interleukin 1
Study 33657052 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33657052 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 33657052 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 33360708 — Predictive Biomarker (PRD): SPIN1 mRNA
Genes: SPIN1; OCR; SPIN
Study 34987600 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 34987600 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32183423 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 33234019 — Surrogate Endpoint (SUR): Bone mineral density
Study 33798654 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study 33370763 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 34482042 — Predictive Biomarker (PRD): RRAS mRNA
Genes: RRAS
Study 36484190 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study 34118562 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 35607258 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ARHGEF25 mRNA
Genes: ARHGEF25; GEFT
Study 36064432 — Safety Biomarker (SAF): Hyaluronic acid
Study 34965596 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 33402311 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 36076546 — Surrogate Endpoint (SUR): Serum uric acid
Study 35946912 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33978907 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 32070326 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 32070326 — Predictive Biomarker (PRD): PITRM1 mRNA
Genes: PITRM1; KIAA1104; MP1; PREP
Study 33095760 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 32236522 — Surrogate Endpoint (SUR): Blood pressure
Study 32461105 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35758002 — Predictive Biomarker (PRD): ZNF582 mRNA
Genes: ZNF582
Study 35383908 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33225970 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32112263 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study 35914542 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32369545 — Predictive Biomarker (PRD): SRY mRNA
Genes: SRY; TDF
Study 613425329 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 613425329 — Surrogate Endpoint (SUR): Blood pressure
Study 35020250 — Safety Biomarker (SAF): Hyaluronic acid
Study 35197212 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 32412884 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34535091 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33518152 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33518152 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): NRF2 mRNA
Genes: NFE2L2; NRF2
Study 32041583 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36484428 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 32301204 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34709770 — Surrogate Endpoint (SUR): Probing pocket depth
Study 33289308 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33289308 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32317292 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32654603 — Safety Biomarker (SAF): Hyaluronic acid
Study 35587779 — Predictive Biomarker (PRD): MARCKSL1 mRNA
Genes: MARCKSL1; MLP; MRP
Study 35392020 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 32073417 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 34558301 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 34558301 — Surrogate Endpoint (SUR): Blood pressure
Study 32369830 — Surrogate Endpoint (SUR): Blood pressure
Study 35411401 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study 32408253 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 32408253 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study 32408253 — Predictive Biomarker (PRD): COL3A1 mRNA
Genes: COL3A1
Study 32408253 — Predictive Biomarker (PRD): COL5A1 mRNA
Genes: COL5A1
Study 32408253 — Predictive Biomarker (PRD): LOX mRNA
Genes: LOX
Study 32333512 — Safety Biomarker (SAF): Hyaluronic acid
Study 32705528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36103251 — Predictive Biomarker (PRD): UBB mRNA
Genes: UBB
Study 35249338 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 32648390 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 32844540 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 32844540 — Surrogate Endpoint (SUR): Blood pressure
Study 34418014 — Surrogate Endpoint (SUR): Blood pressure
Study 33098463 — Surrogate Endpoint (SUR): Blood pressure
Study 32762677 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study 32762677 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34313610 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32483076 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 32974732 — Surrogate Endpoint (SUR): Serum potassium
Study 35615013 — Surrogate Endpoint (SUR): Blood pressure
Study 35257962 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32755413 — Surrogate Endpoint (SUR): Blood pressure
Study 36163885 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 36324139 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 33801019 — Surrogate Endpoint (SUR): Bone mineral density
Study 32112556 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34989171 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34989171 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34989171 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33048879 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32568065 — Surrogate Endpoint (SUR): Blood pressure
Study 33781228 — Surrogate Endpoint (SUR): Blood pressure
Study 35664492 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35664492 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32339235 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 32423930 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34279564 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 34343032 — Predictive Biomarker (PRD): VIT mRNA
Genes: VIT; UNQ647/PRO1277
Study 33220354 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33035457 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study 32853747 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 33462580 — Predictive Biomarker (PRD): IVNS1ABP mRNA
Genes: IVNS1ABP; ARA3; FLARA3; KIAA0850; KLHL39; NS1; NS1BP; HSPC068
Study 35401732 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 33782715 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34551229 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34551229 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 34551229 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 36235848 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 34022790 — Surrogate Endpoint (SUR): Blood pressure
Study 34022790 — Surrogate Endpoint (SUR): Serum sodium
Study 32773308 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32491006 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32751170 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36224294 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36224294 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 33621541 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 33574070 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32706937 — Predictive Biomarker (PRD): Hormone receptor
Study 32706937 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32785654 — Surrogate Endpoint (SUR): Bone mineral density
Study 34580975 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 34580975 — Surrogate Endpoint (SUR): Blood pressure
Study 34943854 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4